1AI — Algorae Pharmaceuticals Share News
0.000.00%
- AU$18.58m
- AU$16.69m
- AU$0.14m
Australia Stock Exchange release from LIVING CELL TECH : LCT Signs MOU with NZeno, Secures Pig Cells for NTCELL Trial
Australia Stock Exchange release from LIVING CELL TECH : Application for quotation of securities - LCT
Brief: Living Cell Technologies Secures Funding For Third Clinical Trial Of NTCELL In Parkinson's Disease
Australia Stock Exchange release from LIVING CELL TECH : Cleansing Notice
Australia Stock Exchange release from LIVING CELL TECH : Proposed issue of securities - LCT
Australia Stock Exchange release from LIVING CELL TECH : PRE_NR Ends: 09:53:03
Australia Stock Exchange release from LIVING CELL TECH : Secures Funds for 3rd Trial of NTCELL in Parkinson Disease
Brief: Living Cell Technologies Seeks Trading Halt
Australia Stock Exchange release from LIVING CELL TECH : Trading Halt
Australia Stock Exchange release from LIVING CELL TECH : Pause in Trading
Australia Stock Exchange release from LIVING CELL TECH : Appendix 4G and Corporate Governance Statement
Australia Stock Exchange release from LIVING CELL TECH : Annual Report to shareholders
Australia Stock Exchange release from LIVING CELL TECH : 2021 Annual General Meeting
Australia Stock Exchange release from LIVING CELL TECH : Notification of cessation of securities - LCT
Australia Stock Exchange release from LIVING CELL TECH : Preliminary Final Report and 2021 Financial Statements
Australia Stock Exchange release from LIVING CELL TECH : PRE_NR Ends: 09:59:44
Australia Stock Exchange release from LIVING CELL TECH : Business Update
Australia Stock Exchange release from LIVING CELL TECH : Appendix 3Z - K Taylor
Brief: Living Cell Technologies Says Appointed Bernie Tuch As Interim Ceo